Modafinil and Atacand drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Modafinil (modafinil) and Atacand (candesartan cilexetil). Common drug interactions include confusional state among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Modafinil and Atacand. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Modafinil?

Modafinil has active ingredients of modafinil. It is often used in narcolepsy. eHealthMe is studying from 20,805 Modafinil users. Check the latest studies of Modafinil.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.



On Jul, 29, 2026

16 people who take Modafinil and Atacand together, and have interactions are studied.

Modafinil and Atacand drug interactions.

What are the common drug interactions of Modafinil and Atacand, by gender? *:

female:

  1. Confusional state
  2. Headache (pain in head)
  3. Pyrexia (fever)
  4. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  5. Impaired gastric emptying
  6. Muscle spasms (muscle contraction)
  7. Nausea (feeling of having an urge to vomit)
  8. Nerve injury
  9. Stress
  10. Abdominal pain

male:

  1. Drug ineffective
  2. Insomnia (sleeplessness)
  3. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  4. Therapeutic response unexpected
  5. Arthralgia (joint pain)
  6. Chronic kidney disease
  7. Renal failure (kidney dysfunction)
  8. Renal injury (kidney injury)

What are the common drug interactions of Modafinil and Atacand, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)

40-49:

n/a

50-59:

  1. Depression
  2. Headache (pain in head)
  3. Pyrexia (fever)
  4. Abdominal pain
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Asthenia (weakness)
  7. Breath sounds
  8. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  9. Confusional state
  10. Dizziness

60+:

  1. Drug ineffective
  2. Insomnia (sleeplessness)
  3. Nausea (feeling of having an urge to vomit)
  4. Renal failure (kidney dysfunction)
  5. Renal injury (kidney injury)
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  7. Therapeutic response unexpected
  8. Arthralgia (joint pain)
  9. Chronic kidney disease
  10. Confusional state

What are the existing conditions these people have? *

  1. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 31.25%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 12.50%
  3. Hypersensitivity: 2 people, 12.50%
  4. Sleep Apnea Syndrome: 1 person, 6.25%
  5. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 6.25%
  6. Prostatic Adenoma (prostatic non-cancerous tumour): 1 person, 6.25%
  7. Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 6.25%
  8. Pain: 1 person, 6.25%
  9. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 6.25%
  10. Joint Pain: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Modafinil and Atacand?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Modafinil and Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Modafinil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Modafinil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atacand and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on modafinil and candesartan cilexetil (the active ingredients of Modafinil and Atacand, respectively), and Modafinil and Atacand (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: